本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Gyre Therapeutics

7.70
-0.0134-0.17%
成交量:9.48万
成交额:70.62万
市值:7.41亿
市盈率:371.35
高:7.75
开:7.63
低:7.02
收:7.71
52周最高:19.00
52周最低:6.11
股本:9,631.32万
流通股本:2,594.58万
量比:4.08
换手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):0.0207
每股收益(LYR):0.1420
净资产收益率:7.84%
总资产收益率:4.27%
市净率:8.06
市盈率(LYR):54.19

数据加载中...

公司资料

公司名字:
Gyre Therapeutics
交易所:
NASDAQ
成立时间:
2002
员工人数:
579
公司地址:
12770 High Bluff Drive,Suite 150,San Diego,California,United States
邮编:
92130
电话:
传真:
- -
简介:
Gyre Therapeutics, Inc.在特拉华州注册成立。该公司及其子公司是一家生物制药公司,该公司是一家生物制药公司,致力于研究、开发、制造和商业化治疗器官纤维化的创新药物。

董事

名称
职位
Ping Zhang
Executive Chair, Interim Chief Executive Officer
David M. Epstein
Independent Director
Gordon G. Carmichael
Independent Director
Renate Parry
Independent Director
Rodney L. Nussbaum
Independent Director
Songjiang Ma
President and Director
Dan Weng
Director
Thomas Eastling
Director

股东

名称
职位
Ping Zhang
Executive Chair, Interim Chief Executive Officer
Weiguo Ye
Chief Operating Officer
Han Ying
Senior Vice President, Science
Ruoyu Chen
Chief Financial Officer and Principal Accounting Officer
Songjiang Ma
President and Director